We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
+11.71%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$7.51B
AUM Growth
+$668M
(+9.8%)
Cap. Flow
+$14M
Cap. Flow
% of AUM
0.19%
Top 10 Holdings %
Top 10 Hldgs %
34.2%
Holding
1,319
New
77
Increased
462
Reduced
700
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$45.1M |
| 2 |
Home Depot
HD
|
+$13.5M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$10.9M |
| 4 |
Salesforce
CRM
|
+$10.2M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$10.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$9.39M |
| 2 |
Coca-Cola
KO
|
+$9.33M |
| 3 |
United Parcel Service
UPS
|
+$8.35M |
| 4 |
IBM
IBM
|
+$7.74M |
| 5 |
Union Pacific
UNP
|
+$6.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 12.56% |
| 3 | Healthcare | 12.54% |
| 4 | Financials | 10.24% |
| 5 | Communication Services | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
1101
DELISTED
Select Medical
SEM
| $243K | ﹤0.01% |
+14,128
| New | +$219K |
|
1102
Duolingo
DUOL
$6.72B
| $242K | ﹤0.01% |
+1,692
| New | +$242K |
|
1103
Sensata Technologies
ST
$6.19B
| $240K | ﹤0.01% |
5,342
-12
| -0.2% | -$526 |
|
|
AEL
1104
DELISTED
American Equity Investment Life Holding Company
AEL
| $240K | ﹤0.01% |
+4,611
| New | +$185K |
|
1105
Academy Sports + Outdoors
ASO
$2.66B
| $239K | ﹤0.01% |
4,430
| – | – |
|
|
ALTR
1106
DELISTED
Altair Engineering Inc
ALTR
| $239K | ﹤0.01% |
3,145
+133
| +4% | +$9.51K |
|
1107
Phillips Edison & Co
PECO
$5.08B
| $237K | ﹤0.01% |
6,959
-354
| -5% | -$11.1K |
|
1108
Mercury Systems
MRCY
$5.43B
| $236K | ﹤0.01% |
6,812
-552
| -7% | -$23.6K |
|
1109
Matsons
MATX
$6.73B
| $235K | ﹤0.01% |
+3,023
| New | +$207K |
|
1110
Navient
NAVI
$886M
| $235K | ﹤0.01% |
12,631
-4,420
| -26% | -$72.6K |
|
1111
Carlyle Group
CG
$17.7B
| $235K | ﹤0.01% |
7,344
-16
| -0.2% | -$467 |
|
1112
Zurn Elkay Water Solutions
ZWS
$8.09B
| $234K | ﹤0.01% |
+8,714
| New | +$198K |
|
1113
Guardant Health
GH
$22.1B
| $234K | ﹤0.01% |
6,545
-6,953
| -52% | -$200K |
|
1114
Robinhood
HOOD
$98.8B
| $229K | ﹤0.01% |
22,952
+3,281
| +17% | +$30.6K |
|
1115
Herc Holdings
HRI
$5.24B
| $228K | ﹤0.01% |
+1,666
| New | +$184K |
|
1116
H.B. Fuller
FUL
$3.07B
| $228K | ﹤0.01% |
3,182
+66
| +2% | +$4.34K |
|
|
GAP
1117
The Gap Inc
GAP
$9.1B
| $226K | ﹤0.01% |
25,337
-2,291
| -8% | -$20.4K |
|
1118
Federal Signal
FSS
$7.34B
| $226K | ﹤0.01% |
+3,527
| New | +$195K |
|
|
BPMC
1119
DELISTED
Blueprint Medicines
BPMC
| $225K | ﹤0.01% |
+3,556
| New | +$193K |
|
1120
SM Energy
SM
$8.81B
| $224K | ﹤0.01% |
+7,091
| New | +$200K |
|
1121
Magnolia Oil & Gas
MGY
$6.34B
| $224K | ﹤0.01% |
10,704
-183
| -2% | -$3.78K |
|
1122
State Street SPDR S&P Software & Services ETF
XSW
$534M
| $223K | ﹤0.01% |
1,674
-880
| -34% | -$108K |
|
1123
Strategy Inc
MSTR
$53.9B
| $223K | ﹤0.01% |
+6,510
| New | +$197K |
|
|
JBTM
1124
JBT Marel
JBTM
$6.16B
| $222K | ﹤0.01% |
1,834
-167
| -8% | -$18.3K |
|
1125
SPX Corp
SPXC
$10.3B
| $219K | ﹤0.01% |
+2,582
| New | +$192K |
|
Similar funds
PCM
LPC
CAM
MFG
PAM
BS
BBVA
NMO
Xponance's Q2 2023 Portfolio in Review
As of Q2 2023, Xponance held 1,319 positions worth $7.51B, up 9.8% from $6.84B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Xponance's Q2 2023 filing shows 77 new, 462 increased, 700 reduced and 61 closed positions. Its largest new stake was Coupang: 152,372 shares worth $2.65M. The largest sale was Procter & Gamble, an estimated $9.39M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Xponance's largest Q2 2023 buy was Coupang: 152,372 shares worth $2.65M.
- Xponance added most to Meta Platforms (Facebook) in Q2 2023, an estimated $45.1M increase.
- Xponance's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $9.39M.
- Xponance fully exited iShares Core MSCI International Developed Markets ETF in Q2 2023, selling an estimated $681K.
- Xponance's ten largest holdings make up 34% of its $7.51B portfolio in Q2 2023.
- Xponance opened 77 new positions and closed 61 in Q2 2023.
- Xponance's portfolio value rose 9.8% quarter-over-quarter to $7.51B.
Based on Xponance's 13F filing for Q2 2023, filed 14 Jul 2023.